These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8853493)

  • 1. The American Cancer Society's National Prostate Cancer Detection Project.
    Littrup PJ
    Can J Oncol; 1994 Nov; 4 Suppl 1():65-9. PubMed ID: 8853493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening. Appropriate choices? Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Littrup PJ
    Cancer; 1994 Oct; 74(7 Suppl):2016-22. PubMed ID: 7522122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC; Mettlin CJ; Murphy GP
    J Urol; 1994 Nov; 152(5 Pt 2):1873-7. PubMed ID: 7523734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC; Mettlin CJ
    CA Cancer J Clin; 1993; 43(3):134-49. PubMed ID: 7683964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A
    Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and benefits of prostate cancer screening. Investigators of the American Cancer Society--National Prostate Cancer Detection Project.
    Littrup PJ; Goodman AC
    In Vivo; 1994; 8(3):423-7. PubMed ID: 7803728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for prostate cancer.
    Waldman AR; Osborne DM
    Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer. A decision analytic view.
    Krahn MD; Mahoney JE; Eckman MH; Trachtenberg J; Pauker SG; Detsky AS
    JAMA; 1994 Sep; 272(10):773-80. PubMed ID: 7521400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of prostate cancer early detection.
    Mettlin C
    Cancer; 1993 Aug; 72(3 Suppl):1050-5. PubMed ID: 7687518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening of prostate carcinoma].
    Trinkler FB
    Ther Umsch; 1995 Jun; 52(6):393-8. PubMed ID: 7541568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
    Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
    Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of prostate cancer following repeated examinations by multiple modalities: results of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C
    Clin Invest Med; 1993 Dec; 16(6):440-7. PubMed ID: 7516832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density, and PSA change. Data from the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Littrup PJ; Kane RA; Murphy GP; Lee F; Chesley A; Badalament R; Mostofi FK
    Cancer; 1994 Sep; 74(5):1615-20. PubMed ID: 7520352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
    Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
    JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer screening with PSA, DRE and TRUS.
    Cusan L
    Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
    [No Abstract]   [Full Text] [Related]  

  • 17. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
    Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer screening.
    Roetzheim RG; Herold AH
    Prim Care; 1992 Sep; 19(3):637-49. PubMed ID: 1384077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument for.
    Brawer MK
    Eur Urol; 1996; 29 Suppl 2():19-23. PubMed ID: 8717456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.